Physicians' Academy for Cardiovascular Education

e-Counselling tool enhanced efficacy of usual care for hypertension

e-Counseling for Self-Care Adherence Adds Therapeutic Benefit for Hypertension: The REACH Trial

Presented at ACC.17 by Rob Nolan

News - Mar. 19, 2017

Main results

Conclusion

These data show that the e-counselling programme enhanced efficacy of usual care for hypertension at 12 months. Clinically meaningful outcomes were seen, including a 10 mmHg lower SBP, which is associated with risk reductions of 20% of CVD events, 17% CHD, 27% stroke and 13% all-cause mortality. These findings provide support for a scalable phase III e-counselling trial for hypertension.

During the press conference, it was noted that in daily clinical practice, it is difficult to counsel patients adequately in a 10-minute appointment. This e-counselling method targeted at a motivational, evidence-based intervention, in a well-thought-out combination of factors, can therefore be a powerful additive approach in hypertension management. The physicians in the discussion panel agreed that it would be helpful to have an extra tool to improve compliance.

Dr. Nolan mentioned that future versions will include technology to track online which components of the programme worked best. After some additional work, they aim to make the core app freely available.

Subanalyses have not resulted in insights that may explain the gender differences observed.

Disclosures

Our coverage of ACC.17 is based on the information provided during the congress.

Share this page with your colleagues and friends: